Ironwood Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio805.6010.863.6117.17
Forward P/E13.4214.1411.248.4310.89
P/S Ratio2.024.034.634.614.68
P/B Ratio-2.35-5.162.913.1529.11
Price/Tangible Book2.913.1529.11
Price/FCF6.869.756.957.2910.92
Price/OCF6.859.746.947.2910.80
PEG Ratio1.982.251.210.71
Enterprise Value Ratios
EV/Revenue3.525.454.244.365.04
EV/EBITDA12.6412.236.927.7212.22
EV/EBIT12.9112.336.967.7712.41
EV/FCF11.9513.186.376.8911.76
Profitability & Returns
Return on Equity (ROE)-6.74%0.28%1.58%
Return on Assets (ROA)0.15%0.16%0.14%0.17%0.21%
Return on Invested Capital (ROIC)0.01%0.57%0.40%0.75%0.98%
Return on Capital Employed (ROCE)0.31%1.00%0.23%0.24%0.30%
Leverage & Solvency Ratios
Debt/Equity-1.99-2.070.640.797.24
Debt/EBITDA5.893.561.632.012.76
Debt/FCF5.803.911.521.822.72
Liquidity Ratios
Current Ratio4.700.8430.584.6115.41
Quick Ratio4.390.8030.234.5415.07
Efficiency Ratios
Asset Turnover0.850.560.370.490.81
Yield & Distribution Ratios
Earnings Yield0.00%-0.56%0.09%0.28%0.06%
FCF Yield0.15%0.10%0.14%0.14%0.09%
Buyback Yield-0.03%0.17%-0.13%-0.02%-0.03%